Related references
Note: Only part of the references are listed.DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer
Zhong Wang et al.
CELL DEATH & DISEASE (2020)
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Yi-Zhou Jiang et al.
CANCER CELL (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
mTORC2 Suppresses GSK3-Dependent Snail Degradation to Positively Regulate Cancer Cell Invasion and Metastasis
Shuo Zhang et al.
CANCER RESEARCH (2019)
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly
Pia Giovannelli et al.
SCIENTIFIC REPORTS (2019)
Epithelial mesenchymal transition and resistance in endocrine-related cancers
Zoran Culig
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer
Nami Yamashita et al.
CLINICAL BREAST CANCER (2018)
EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
Nicole M. Aiello et al.
DEVELOPMENTAL CELL (2018)
The cellular and molecular effects of the androgen receptor agonist, Cl-4AS-1, on breast cancer cells
Mamoun Ahram et al.
ENDOCRINE RESEARCH (2018)
Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells
Nihad Al-Othman et al.
GENE (2018)
Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) delta/epsilon
Balbina Garcia-Reyes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
Kristine Astvatsaturyan et al.
PLOS ONE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression
Anna Linder et al.
SCIENTIFIC REPORTS (2018)
A Cell Model Suitable for a High-Throughput Screening of Inhibitors of the Wnt/β-Catenin Pathway
Marina Grimaldi et al.
FRONTIERS IN PHARMACOLOGY (2018)
Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms
J. Feng et al.
ONCOGENE (2017)
Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond
Mary Nakazawa et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland
Hubert Pakula et al.
CANCERS (2017)
Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer
Rui Huang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer
Yan Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Differential expression and androgen regulation of microRNAs and metalloprotease 13 in breast cancer cells
Mamoun Ahram et al.
CELL BIOLOGY INTERNATIONAL (2017)
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
A. Thakkar et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells
Francesco Caiazza et al.
ENDOCRINE-RELATED CANCER (2016)
Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells
Juliane Colditz et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis
Changjun Wang et al.
ONCOTARGET (2016)
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling
Maria Magdalena Montt-Guevara et al.
FRONTIERS IN ENDOCRINOLOGY (2016)
Tumor Budding: The Name is EMT. Partial EMT.
Alexandru Dan Grigore et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition
Yifeng Jing et al.
CANCER LETTERS (2014)
Revising the role of the androgen receptor in breast cancer
F. M. Fioretti et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Epithelial plasticity in prostate cancer: principles and clinical perspectives
Rajdeep Das et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Dawn R. Cochrane et al.
BREAST CANCER RESEARCH (2014)
TGF-β-Id1 Signaling Opposes Twist1 and Promotes Metastatic Colonization via a Mesenchymal-to-Epithelial Transition
Marko Stankic et al.
CELL REPORTS (2013)
Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
N. P. A. Devika Gunasinghe et al.
CANCER AND METASTASIS REVIEWS (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Expression of Wnt3 Activates Wnt/β-Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
Yanyuan Wu et al.
MOLECULAR CANCER RESEARCH (2012)
The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
T. E. Hickey et al.
MOLECULAR ENDOCRINOLOGY (2012)
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Min Ni et al.
CANCER CELL (2011)
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
Jessica L. L. Robinson et al.
EMBO JOURNAL (2011)
Differential Effects of Exogenous Androgen and an Androgen Receptor Antagonist in the Peri- and Postpubertal Murine Mammary Gland
A. A. Peters et al.
ENDOCRINOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers
Y. Wang et al.
ONCOGENE (2011)
Androgen Receptor Regulates Transcription of the ZEB1 Transcription Factor
Bynthia M. Anose et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2011)
Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells.
TR Graham et al.
CANCER RESEARCH (2010)
Inhibition of Glycogen Synthase Kinase-3β Promotes Nuclear Export of the Androgen Receptor Through a CRM1-Dependent Mechanism in Prostate Cancer Cell Lines
Stefanie V. Schuetz et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Baozhi Chen et al.
NATURE CHEMICAL BIOLOGY (2009)
The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens
Liang Schweizer et al.
BMC CELL BIOLOGY (2008)
Crosstalk between the Androgen Receptor and beta-Catenin in Castrate-Resistant Prostate Cancer
Gang Wang et al.
CANCER RESEARCH (2008)
Androgen receptor and invasion in prostate cancer
Takahito Hara et al.
CANCER RESEARCH (2008)
Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers
Yoshinari Ogawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Structural basis for the nuclear import of the human androgen receptor
Mark L. Cutress et al.
JOURNAL OF CELL SCIENCE (2008)
A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer
Ali Naderi et al.
NEOPLASIA (2008)
Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women
Marie Hofling et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)
Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility
Marco Marcelli et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
A. S. Doane et al.
ONCOGENE (2006)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
The androgen receptor can promote β-catenin nuclear translocation independently of adenomatous polyposis coli
DJ Mulholland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
